Table 4

Univariate and Multivariate Analysis for Prediction of Long-Term CV Mortality With CRT

No CV Death
(n = 159)
CV Death
(n = 30)
Univariate
HR (95% CI)
p ValueMultivariate
HR (95% CI)
p Value
Age, yrs66.7 ± 9.170.1 ± 7.91.04 (0.99–1.09)0.078
Female36 (22.6)7 (23.3)0.88 (0.38–2.08)0.772
Ischemic cardiomyopathy60 (37.7)13 (43.3)1.45 (0.70–3.01)0.315
Creatinine, mg/dl1.2 ± 0.51.5 ± 0.72.58 (1.51–4.41)<0.0013.26 (0.72–14.82)0.127
Atrial fibrillation48 (30.2)15 (50)2.82 (1.33–5.96)<0.010.16 (0.02–1.38)0.095
QRS width, ms169.6 ± 29.5169.5 ± 37.00.99 (0.98–1.01)0.897
LBBB110 (69.2)20 (66.7)0.94 (0.44–2.02)0.868
NYHA functional class IV11 (6.9)7 (23.3)4.93 (2.17–11.20)<0.0016.03 (1.14–31.76)0.034
LVEF, %24.7 ± 6.422.1 ± 5.80.93 (0.88–0.99)0.0330.94 (0.82–1.09)0.426
LVEDD, mm70.6 ± 9.170.8 ± 7.51.00 (0.96–1.05)0.909
LVESD, mm57.5 ± 10.657.3 ± 8.31.00 (0.96–1.04)0.971
LVEDV, ml262.9 ± 88.6245.3 ± 69.71.00 (0.99–1.00)0.384
LVESV, ml200.5 ± 77.5204.4 ± 82.31.00 (1.00–1.01)0.640
Filling time, %42.7 ± 9.938.9 ± 7.30.96 (0.90–1.02)0.225
Septal-to-lateral delay, ms70.6 ± 49.762.4 ± 50.51.00 (0.99–1.01)0.563
Transmurality index0.5 ± 0.71.1 ± 1.12.07 (1.07–4.00)0.0311.60 (0.65–3.98)0.307
Presence of abnormality121 (76.1)17 (56.7)0.37 (0.18–0.78)<0.010.11 (0.20–0.60)0.011

Values are mean ± SD or n (%).

CV = cardiovascular; HR = hazard ratio; other abbreviations as in Tables 1, 2, and 3.